维持性血液透析患者血浆钙浓度对体内炎症介质的影响及机制研究
|
摘要
第一部分维持性血液透析患者血浆钙浓度对体内炎症介质及脉搏波速的影响
目的
脉搏波速是能准确反映动脉粥样硬化程度的早期指标,能够综合反映各种危险因素对血管的损伤,探讨维持性血液透析(MHD)患者血浆钙浓度对体内炎症介质及脉搏波速的影响,进一步了解导致MHD患者心血管并发症的危险因素,防治并发症的发生发展。
方法
1 MHD患者63例分成两组(A组和B组),A组31例为血浆钙浓度正常范围的患者,B组32例为血浆钙浓度低于正常范围的患者,透析前空腹留血3ml ,乙二胺四乙酸(EDTA)抗凝,1500rpm离心10min,收集血浆,置-20℃冰箱保存待测。
2由我院生化室检测肾功,肝功,血脂及血浆钙浓度;采用酶联免疫吸附实验(ELISA)检测C反应蛋白(CRP)、白介素6(IL-6)、总同型半胱氨酸(tHcy)、全段甲状旁腺素(iPTH)水平;
3采用脉搏波传导速度(PWV)分析仪测定颈股脉搏波传导速度(CF-PWV);
4应用SPSS13.0统计软件包处理数据,计量资料以( x±S)表示,分类变量间比较进行卡方检验,采用两均数比较的t检验,直线相关分析,多元线性回归分析,多元Logistic回归分析。P<0.05为统计学差异有显著性。
结果
1 A组CRP、IL-6、tHcy、iPTH、及CF-PWV明显低于B组(P<0.05);
2 63例患者用直线相关分析表明MHD患者血浆钙浓度与CRP、IL-6、tHcy、iPTH及CF-PWV呈负相关关系;
3分别以CRP、tHcy和IL-6为应变量,血钙、血肌酐、血清白蛋白、血胆固醇、甘油三酯及透析龄为自变量进行多元回归分析,血钙及透析龄进入CRP和tHcy的回归方程,说明血钙浓度高低及透析龄长短与CRP和tHcy水平相关,透析龄进入IL-6的回归方程,说明透析龄长短与IL-6水平相关;
4以CF-PWV为应变量,透析龄、血钙、CRP、IL-6、tHcy、iPTH为自变量进行多元回归分析,透析龄、血钙、CRP、tHcy进入回归方程,说明透析龄、血钙浓度、CRP及tHcy水平与CF-PWV相关;
5以CF-PWV增快(CF-PWV≧9.8m/s,中位数)将63例患者分为两组并以它为应变量,性别、年龄、吸烟、糖尿病、收缩压、舒张压、透析龄、血钙、CRP、IL-6、tHcy和iPTH为自变量进行多元逐步Logistic回归分析,透析龄,血钙及tHcy进入了回归方程,说明透析龄、血钙浓度及tHcy水平与CF-PWV增快有关。
结论
1 MHD患者血浆钙浓度降低与炎症介质CRP及tHcy水平升高密切相关;
2除透析龄外,血钙及tHcy是影响颈股脉搏波传导速度的独立危险因素。
第二部分不同浓度的氯化钙对MHD患者PBMC炎症介质及PKC,NF-κB的影响
目的
在临床观察结果基础上,进一步探讨不同的钙离子浓度对MHD患者外周血单个核细胞(PBMC)炎症介质及细胞内蛋白激酶C(PKC)、核转录因子-κB(NF-κB)的影响。
方法
1健康志愿者和MHD患者各6例,取外周静脉血分离获得外周血单个核细胞,单个核细胞以5×105个细胞/孔种入96孔细胞培养板,分5组,分别加入不同浓度的氯化钙。A组:健康志愿者PBMC;B组:MHD患者PBMC;C组:MHD患者PBMC+1.0mmol/LCaCL2;D组:MHD患者PBMC+1.25mmol/LCaCL2,E组:MHD患者PBMC+1.5mmol/LCaCL2,培养细胞12小时。
2观察培养前后细胞形态变化;
3收集各组细胞培养上清检测CRP及IL-6水平,收获细胞后分别检测胞内钙离子浓度、PKC及NF-κB。
结果
1各组细胞培养前后细胞形态、数量无明显变化;
2各组细胞培养前后胞内钙离子浓度差异无显著性;
3健康者与未加氯化钙培养的细胞,培养上清中CRP、IL-6水平及PKC、NF-κB含量无明显差异;
4加入1.0mmol/LCaCL2组细胞培养12小时后CRP、IL-6水平及PKC、NF-κB含量明显低于1.5mmol/LCaCL2组。
结论
1不同浓度的氯化钙不影响MHD患者PBMC的形态和数量;
2不同浓度的氯化钙对MHD患者PBMC胞内钙离子浓度无明显影响;
3不同浓度的氯化钙不影响健康者和MHD患者PBMC培养上清CRP、IL-6的水平及胞内PKC、NF-κB的含量;
4低浓度钙明显抑制MHD患者PBMC培养上清CRP及IL-6的生成,明显减少胞内PKC及NF-κB的含量。
第三部分脂多糖和氯化钙对MHD患者PBMC炎症介质及PKC、NF-κB的影响
目的
MHD患者体内存在多种炎症介质,对患者的PBMC产生炎症因子有一定影响。本部分实验拟进一步探讨在炎症介质刺激下,不同浓度的氯化钙对MHD患者PBMC炎症因子的产生及细胞内PKC、NF-κB的影响。
方法
1健康志愿者和MHD患者各6例,取外周静脉血分离获得PBMC,PBMC以5×105个细胞/孔种入96孔细胞培养板,每孔均加入LPS,其终浓度为100ng/ml,分5组。A1组:正常人PBMC;B1组:患者PBMC;C1组:患者PBMC+1.0mmol/LCaCL2;D1组:患者PBMC+1.25mmol/LCaCL2;E1组:患者PBMC+1.5mmol/LCaCL2;培养12小时。
2观察培养前后细胞形态变化;
3收集各组细胞培养上清检测CRP及IL-6水平,收获细胞后分别检测胞内钙离子浓度、PKC及NF-κB。
结果
1各组细胞培养前后细胞形态、数量无明显变化;
2各组细胞培养前后,细胞内钙离子浓度差异无显著性;
3健康者与MHD患者未加氯化钙培养的PBMC,培养上清中CRP、IL-6水平及PKC、NF-κB含量无明显差异;
4加入1.0mmol/LCaCL2组细胞培养12小时后,细胞产生CRP、IL-6及细胞内PKC、NF-κB含量明显高于1.5mmol/LCaCL2组。
结论
1在LPS的刺激下,不同浓度的氯化钙不影响培养的MHD患者PBMC形态和数量;
2三种浓度的氯化钙对LPS刺激培养的MHD患者PBMC胞内钙离子浓度无明显影响(均P>0.05);
3在LPS的刺激下,不同浓度的氯化钙不影响健康者和MHD患者PBMC培养上清CRP、IL-6的水平及胞内PKC、NF-κB的含量;
4在LPS的刺激下,低浓度钙明显增加MHD患者PBMC培养上清CRP、IL-6的生成及胞内PKC及NF-κB的含量。
Chapter 1
EFFECTS OF THE BLOOD PLASM CALCIUM CONCENTRATION ON INFLAMMATION MEDIATORS AND PULSE WAVE VELOCITY IN MAINTENANCE HEMODIALYSIS PATIENTS
Objective
Pulse wave velocity is a earlier index of atherosclerosis level and can reflect damage of all kinds of risk factors on blood vessel. It conduced to understand risk factors of cardiovascular complication and prevent and cure these complications for investigating the effects of blood plasm calcium concentration on inflammation mediators and pulse wave velocity in maintenance hemodialysis patients
Methods
1 Sixty three maintenance hemodialysis patients were divided into two groups(A group n=31 and B group n=32). The blood plasm calcium concentrations of A group were in normal range.The blood plasm of 3 mL venous blood,anticoagulation by ethylene diamine tetraacetic acid,centrifugation 10 minutes by 1500 rpm,were preserved in -20℃refrigerator for measuring.
2 Results of hepatic function,renal function,blood fat and the blood plasm calcium density were from our biochemistry compartment,C reactive protein(CRP),interleukin-6(IL-6),total Homocysteine(tHcy),parathyroid hormone(iPTH) were measured by enzyme-linked immunosorbent assay.
3 carotid-femoral pulse wave velocity(CF-PWV) were detected by PWV analysator.
4 SPSS 13.0 statistical package were utilized for handling data,measurement data were expressed as arithmetic mean and standard deviation( x±s).The comparisons between the stydy groups were performed with chi square test,t test,linear correlation analysis,multiple linear regression analysis and multiple logistic regression analysis.
Results
1 The levels of CRP, IL-6,tHcy ,iPTH and CF-PWV in A group were lower than those of B group(p﹤0.05);
2 There was a negative correlation among the blood calcium concentration and CRP and IL-6 and iPTH and tHcy and CF-PWV in 63 patients by linear correlation analysis;
3 By multiple linear regression analysis,levels of blood calcium concentration and dialysis time correlated with levels of CRP and tHcy , dialysis time correlated with levels of IL-6;
4 The blood calcium concentration,dialysis time,levels of CRP and tHcy correlated with increase of CF-PWV by multiple linear regression analysis;
5 Tthe blood plasm calcium concentration,dialysis time and levels of tHcy correlated with increase of CF-PWV by multiple logistic regression.
Conclusions
1 There is a significant negative correlation among the blood plasm calcium concentration and CRP and tHcy;
2 In addition to dialysis time, blood plasm calcium concentration and tHcy are independent risk factors of increase of CF-PWV in maintenance hemodialysis.
chapter 2
EFFECT OF DIFFERENT CONCENTRATION CALCIUM CHLORIDE ON PERIPHERAL BLOOD MONONUCLEAR CELL INFLAMMATION MEDIATORS,PKC AND NF-κB IN MHD PATIENTS
Objective
According to prophase clinical observe founds,continually investigating the effect of calcium chloride of different concentration on peripheral blood inflammation mediators,PKC and NF-κB in MHD patients .
Methods
1 Peripheral blood mononuclear cells,from 6 healthy volunteers and 6 MHD patients were obtained after centrifugalization,5×105PBMCs/well ,seeded in 96 wells cell culture plate were divided into 5 groups for cultivating 12 hours.A group:normal PBMC,B group:patient PBMC,C group: patient PBMC+1.0mmol/L Cacl2,D group: patient PBMC+1.25mmol/L Cacl2,E Group: patient PBMC+1.5mmol/L Cacl2;
2 Cell morphologic changes before and after culture were observed; CRP and IL-6 of culture supernatant were detected by ELISA; calcium ion concentration within cells were measured by Fluo-3 AM;
3 PKC and NF-κB within cells were detected by western blot.
Results
1 Cell appearance and amount before and after 12 hours culture didn,t show marked change in every groups;
2 Discrepancies of calcium ion concentration within cells after cultivating 12 hours between every groups were not significant;
3 There were not obvious difference about levels of CRP and IL-6 after 12 hours culture between A and B groups,so were leves of PKC and NF-κB;
4 The levels of CRP and IL-6 in C group after 12 hours culture were lower than E group;so were levels of PKC and NF-κB.
Conclusions
1 Calcium chloride of three kind concentration didn’t affect form and amount of PBMC of MHD patients after cultivating 12 hours ;
2 Discrepancies were not significant about effects of Calcium chloride of three kind concentrations on calcium ion concentration within PBMCs of MHD patients after cultivating 12 hours ;
3 There were not obvious difference about levels of CRP and IL-6 from PBMC between healthy volunteers and MHD patients ;levels of PKC and NF-κB within PBMC in healthy volunteers were not significant,compared with MHD patients after cultivating 12 hours ;
4 Compared with 1.5mmol/L calcium chloride,1.0mmol/L calcium chloride significantly inhibited CRP and IL-6 production of PBMC,reduced levels of PKC and NF-κB within PBMC in MHD patients.
Chapter 3
SYNERGETIC EFFECT OF LIPOPOLYSACCHARIDE AND CALCIUM CHLORIDE ON PERIPHERAL BLOOD MONONUCLEAR CELL INFLAMMATION MEDIATORS ,PKC AND NF-κB IN MHD PATIENTS
Objective
Considering the uremic medium of MHD patients,for instance,PBMC were stimulated by lipopolysaccharide ,advanced glycosylation ends and so on.for this reason,to explore the synergetic effect of lipopolysaccharide and calcium chloride on peripheral blood mononuclear cell inflammation mediators ,PKC and NF-κB in MHD patients progressively .
Methods
1 Peripheral blood mononuclear cells,from 6 healthy volunteers and 6 MHD patients were obtained after centrifugalization,5×105PBMCs/well seeded in 96 wells cell culture plate were divided into 5 groups for cultivating 12 hours.before cultivating,LPS were added in every well,adjusting LPS final concentration as 100ng/ml,A1 group:normal PBMC,B1 group:patient PBMC,C1 group: patient PBMC+1.0mmol/L CaCL2,D1 group: patient PBMC+1.25mmol/L CaCL2,E1 Group: patient PBMC+1.5mmol/L CaCL2.
2 Cell morphologic changes before and after culture were observed,CRP and IL-6 of culture supernatant were detected by ELISA;calcium ion concentration within cells were measured by Fluo-3 AM;
3 PKC and NF-κB within cells were detected by western blot.
Results
1 Cell appearance and amount before and after 12 hours culture didn,t show marked change in every groups;
2 Discrepancies of calcium ion concentration within cells after 12 hours culture between every groups were not significant;
3 There were not obvious difference about levels of CRP and IL-6 between A 1and B1 groups after 12 hours culture;so were levels of PKC and NF-κB;
4 Compared with E1 group;the levels of CRP and IL-6 in C1 group were higher after 12 hours culture ;so were gray levelsof PKC and NF-κB.
Conclusions
1 By stimulus of LPS, Calcium chloride of three kind concentrations didn’t affect form and amount of PBMC of MHD patients after 12 hours culture;
2 Discrepancies were not significant about effects of Calcium chloride of three kind concentrations on calcium ion concentration within PBMC of MHD patients after 12 hours culture under stimulus of LPS;
3 Through stimulus of LPS,there were not obvious difference about levels of CRP and IL-6 from PBMC between healthy volunteers and MHD patients after 12 hours culture;so were levels of PKC and NF-κB;
4 By stimulus of LPS,compared with 1.5mmol/L calcium chloride,1.0mmol/L calcium chloride significantly increased CRP and IL-6 production of PBMC,raised levels of PKC and NF-κB within PBMC in MHD patients after 12 hours culture.
目的
脉搏波速是能准确反映动脉粥样硬化程度的早期指标,能够综合反映各种危险因素对血管的损伤,探讨维持性血液透析(MHD)患者血浆钙浓度对体内炎症介质及脉搏波速的影响,进一步了解导致MHD患者心血管并发症的危险因素,防治并发症的发生发展。
方法
1 MHD患者63例分成两组(A组和B组),A组31例为血浆钙浓度正常范围的患者,B组32例为血浆钙浓度低于正常范围的患者,透析前空腹留血3ml ,乙二胺四乙酸(EDTA)抗凝,1500rpm离心10min,收集血浆,置-20℃冰箱保存待测。
2由我院生化室检测肾功,肝功,血脂及血浆钙浓度;采用酶联免疫吸附实验(ELISA)检测C反应蛋白(CRP)、白介素6(IL-6)、总同型半胱氨酸(tHcy)、全段甲状旁腺素(iPTH)水平;
3采用脉搏波传导速度(PWV)分析仪测定颈股脉搏波传导速度(CF-PWV);
4应用SPSS13.0统计软件包处理数据,计量资料以( x±S)表示,分类变量间比较进行卡方检验,采用两均数比较的t检验,直线相关分析,多元线性回归分析,多元Logistic回归分析。P<0.05为统计学差异有显著性。
结果
1 A组CRP、IL-6、tHcy、iPTH、及CF-PWV明显低于B组(P<0.05);
2 63例患者用直线相关分析表明MHD患者血浆钙浓度与CRP、IL-6、tHcy、iPTH及CF-PWV呈负相关关系;
3分别以CRP、tHcy和IL-6为应变量,血钙、血肌酐、血清白蛋白、血胆固醇、甘油三酯及透析龄为自变量进行多元回归分析,血钙及透析龄进入CRP和tHcy的回归方程,说明血钙浓度高低及透析龄长短与CRP和tHcy水平相关,透析龄进入IL-6的回归方程,说明透析龄长短与IL-6水平相关;
4以CF-PWV为应变量,透析龄、血钙、CRP、IL-6、tHcy、iPTH为自变量进行多元回归分析,透析龄、血钙、CRP、tHcy进入回归方程,说明透析龄、血钙浓度、CRP及tHcy水平与CF-PWV相关;
5以CF-PWV增快(CF-PWV≧9.8m/s,中位数)将63例患者分为两组并以它为应变量,性别、年龄、吸烟、糖尿病、收缩压、舒张压、透析龄、血钙、CRP、IL-6、tHcy和iPTH为自变量进行多元逐步Logistic回归分析,透析龄,血钙及tHcy进入了回归方程,说明透析龄、血钙浓度及tHcy水平与CF-PWV增快有关。
结论
1 MHD患者血浆钙浓度降低与炎症介质CRP及tHcy水平升高密切相关;
2除透析龄外,血钙及tHcy是影响颈股脉搏波传导速度的独立危险因素。
第二部分不同浓度的氯化钙对MHD患者PBMC炎症介质及PKC,NF-κB的影响
目的
在临床观察结果基础上,进一步探讨不同的钙离子浓度对MHD患者外周血单个核细胞(PBMC)炎症介质及细胞内蛋白激酶C(PKC)、核转录因子-κB(NF-κB)的影响。
方法
1健康志愿者和MHD患者各6例,取外周静脉血分离获得外周血单个核细胞,单个核细胞以5×105个细胞/孔种入96孔细胞培养板,分5组,分别加入不同浓度的氯化钙。A组:健康志愿者PBMC;B组:MHD患者PBMC;C组:MHD患者PBMC+1.0mmol/LCaCL2;D组:MHD患者PBMC+1.25mmol/LCaCL2,E组:MHD患者PBMC+1.5mmol/LCaCL2,培养细胞12小时。
2观察培养前后细胞形态变化;
3收集各组细胞培养上清检测CRP及IL-6水平,收获细胞后分别检测胞内钙离子浓度、PKC及NF-κB。
结果
1各组细胞培养前后细胞形态、数量无明显变化;
2各组细胞培养前后胞内钙离子浓度差异无显著性;
3健康者与未加氯化钙培养的细胞,培养上清中CRP、IL-6水平及PKC、NF-κB含量无明显差异;
4加入1.0mmol/LCaCL2组细胞培养12小时后CRP、IL-6水平及PKC、NF-κB含量明显低于1.5mmol/LCaCL2组。
结论
1不同浓度的氯化钙不影响MHD患者PBMC的形态和数量;
2不同浓度的氯化钙对MHD患者PBMC胞内钙离子浓度无明显影响;
3不同浓度的氯化钙不影响健康者和MHD患者PBMC培养上清CRP、IL-6的水平及胞内PKC、NF-κB的含量;
4低浓度钙明显抑制MHD患者PBMC培养上清CRP及IL-6的生成,明显减少胞内PKC及NF-κB的含量。
第三部分脂多糖和氯化钙对MHD患者PBMC炎症介质及PKC、NF-κB的影响
目的
MHD患者体内存在多种炎症介质,对患者的PBMC产生炎症因子有一定影响。本部分实验拟进一步探讨在炎症介质刺激下,不同浓度的氯化钙对MHD患者PBMC炎症因子的产生及细胞内PKC、NF-κB的影响。
方法
1健康志愿者和MHD患者各6例,取外周静脉血分离获得PBMC,PBMC以5×105个细胞/孔种入96孔细胞培养板,每孔均加入LPS,其终浓度为100ng/ml,分5组。A1组:正常人PBMC;B1组:患者PBMC;C1组:患者PBMC+1.0mmol/LCaCL2;D1组:患者PBMC+1.25mmol/LCaCL2;E1组:患者PBMC+1.5mmol/LCaCL2;培养12小时。
2观察培养前后细胞形态变化;
3收集各组细胞培养上清检测CRP及IL-6水平,收获细胞后分别检测胞内钙离子浓度、PKC及NF-κB。
结果
1各组细胞培养前后细胞形态、数量无明显变化;
2各组细胞培养前后,细胞内钙离子浓度差异无显著性;
3健康者与MHD患者未加氯化钙培养的PBMC,培养上清中CRP、IL-6水平及PKC、NF-κB含量无明显差异;
4加入1.0mmol/LCaCL2组细胞培养12小时后,细胞产生CRP、IL-6及细胞内PKC、NF-κB含量明显高于1.5mmol/LCaCL2组。
结论
1在LPS的刺激下,不同浓度的氯化钙不影响培养的MHD患者PBMC形态和数量;
2三种浓度的氯化钙对LPS刺激培养的MHD患者PBMC胞内钙离子浓度无明显影响(均P>0.05);
3在LPS的刺激下,不同浓度的氯化钙不影响健康者和MHD患者PBMC培养上清CRP、IL-6的水平及胞内PKC、NF-κB的含量;
4在LPS的刺激下,低浓度钙明显增加MHD患者PBMC培养上清CRP、IL-6的生成及胞内PKC及NF-κB的含量。
Chapter 1
EFFECTS OF THE BLOOD PLASM CALCIUM CONCENTRATION ON INFLAMMATION MEDIATORS AND PULSE WAVE VELOCITY IN MAINTENANCE HEMODIALYSIS PATIENTS
Objective
Pulse wave velocity is a earlier index of atherosclerosis level and can reflect damage of all kinds of risk factors on blood vessel. It conduced to understand risk factors of cardiovascular complication and prevent and cure these complications for investigating the effects of blood plasm calcium concentration on inflammation mediators and pulse wave velocity in maintenance hemodialysis patients
Methods
1 Sixty three maintenance hemodialysis patients were divided into two groups(A group n=31 and B group n=32). The blood plasm calcium concentrations of A group were in normal range.The blood plasm of 3 mL venous blood,anticoagulation by ethylene diamine tetraacetic acid,centrifugation 10 minutes by 1500 rpm,were preserved in -20℃refrigerator for measuring.
2 Results of hepatic function,renal function,blood fat and the blood plasm calcium density were from our biochemistry compartment,C reactive protein(CRP),interleukin-6(IL-6),total Homocysteine(tHcy),parathyroid hormone(iPTH) were measured by enzyme-linked immunosorbent assay.
3 carotid-femoral pulse wave velocity(CF-PWV) were detected by PWV analysator.
4 SPSS 13.0 statistical package were utilized for handling data,measurement data were expressed as arithmetic mean and standard deviation( x±s).The comparisons between the stydy groups were performed with chi square test,t test,linear correlation analysis,multiple linear regression analysis and multiple logistic regression analysis.
Results
1 The levels of CRP, IL-6,tHcy ,iPTH and CF-PWV in A group were lower than those of B group(p﹤0.05);
2 There was a negative correlation among the blood calcium concentration and CRP and IL-6 and iPTH and tHcy and CF-PWV in 63 patients by linear correlation analysis;
3 By multiple linear regression analysis,levels of blood calcium concentration and dialysis time correlated with levels of CRP and tHcy , dialysis time correlated with levels of IL-6;
4 The blood calcium concentration,dialysis time,levels of CRP and tHcy correlated with increase of CF-PWV by multiple linear regression analysis;
5 Tthe blood plasm calcium concentration,dialysis time and levels of tHcy correlated with increase of CF-PWV by multiple logistic regression.
Conclusions
1 There is a significant negative correlation among the blood plasm calcium concentration and CRP and tHcy;
2 In addition to dialysis time, blood plasm calcium concentration and tHcy are independent risk factors of increase of CF-PWV in maintenance hemodialysis.
chapter 2
EFFECT OF DIFFERENT CONCENTRATION CALCIUM CHLORIDE ON PERIPHERAL BLOOD MONONUCLEAR CELL INFLAMMATION MEDIATORS,PKC AND NF-κB IN MHD PATIENTS
Objective
According to prophase clinical observe founds,continually investigating the effect of calcium chloride of different concentration on peripheral blood inflammation mediators,PKC and NF-κB in MHD patients .
Methods
1 Peripheral blood mononuclear cells,from 6 healthy volunteers and 6 MHD patients were obtained after centrifugalization,5×105PBMCs/well ,seeded in 96 wells cell culture plate were divided into 5 groups for cultivating 12 hours.A group:normal PBMC,B group:patient PBMC,C group: patient PBMC+1.0mmol/L Cacl2,D group: patient PBMC+1.25mmol/L Cacl2,E Group: patient PBMC+1.5mmol/L Cacl2;
2 Cell morphologic changes before and after culture were observed; CRP and IL-6 of culture supernatant were detected by ELISA; calcium ion concentration within cells were measured by Fluo-3 AM;
3 PKC and NF-κB within cells were detected by western blot.
Results
1 Cell appearance and amount before and after 12 hours culture didn,t show marked change in every groups;
2 Discrepancies of calcium ion concentration within cells after cultivating 12 hours between every groups were not significant;
3 There were not obvious difference about levels of CRP and IL-6 after 12 hours culture between A and B groups,so were leves of PKC and NF-κB;
4 The levels of CRP and IL-6 in C group after 12 hours culture were lower than E group;so were levels of PKC and NF-κB.
Conclusions
1 Calcium chloride of three kind concentration didn’t affect form and amount of PBMC of MHD patients after cultivating 12 hours ;
2 Discrepancies were not significant about effects of Calcium chloride of three kind concentrations on calcium ion concentration within PBMCs of MHD patients after cultivating 12 hours ;
3 There were not obvious difference about levels of CRP and IL-6 from PBMC between healthy volunteers and MHD patients ;levels of PKC and NF-κB within PBMC in healthy volunteers were not significant,compared with MHD patients after cultivating 12 hours ;
4 Compared with 1.5mmol/L calcium chloride,1.0mmol/L calcium chloride significantly inhibited CRP and IL-6 production of PBMC,reduced levels of PKC and NF-κB within PBMC in MHD patients.
Chapter 3
SYNERGETIC EFFECT OF LIPOPOLYSACCHARIDE AND CALCIUM CHLORIDE ON PERIPHERAL BLOOD MONONUCLEAR CELL INFLAMMATION MEDIATORS ,PKC AND NF-κB IN MHD PATIENTS
Objective
Considering the uremic medium of MHD patients,for instance,PBMC were stimulated by lipopolysaccharide ,advanced glycosylation ends and so on.for this reason,to explore the synergetic effect of lipopolysaccharide and calcium chloride on peripheral blood mononuclear cell inflammation mediators ,PKC and NF-κB in MHD patients progressively .
Methods
1 Peripheral blood mononuclear cells,from 6 healthy volunteers and 6 MHD patients were obtained after centrifugalization,5×105PBMCs/well seeded in 96 wells cell culture plate were divided into 5 groups for cultivating 12 hours.before cultivating,LPS were added in every well,adjusting LPS final concentration as 100ng/ml,A1 group:normal PBMC,B1 group:patient PBMC,C1 group: patient PBMC+1.0mmol/L CaCL2,D1 group: patient PBMC+1.25mmol/L CaCL2,E1 Group: patient PBMC+1.5mmol/L CaCL2.
2 Cell morphologic changes before and after culture were observed,CRP and IL-6 of culture supernatant were detected by ELISA;calcium ion concentration within cells were measured by Fluo-3 AM;
3 PKC and NF-κB within cells were detected by western blot.
Results
1 Cell appearance and amount before and after 12 hours culture didn,t show marked change in every groups;
2 Discrepancies of calcium ion concentration within cells after 12 hours culture between every groups were not significant;
3 There were not obvious difference about levels of CRP and IL-6 between A 1and B1 groups after 12 hours culture;so were levels of PKC and NF-κB;
4 Compared with E1 group;the levels of CRP and IL-6 in C1 group were higher after 12 hours culture ;so were gray levelsof PKC and NF-κB.
Conclusions
1 By stimulus of LPS, Calcium chloride of three kind concentrations didn’t affect form and amount of PBMC of MHD patients after 12 hours culture;
2 Discrepancies were not significant about effects of Calcium chloride of three kind concentrations on calcium ion concentration within PBMC of MHD patients after 12 hours culture under stimulus of LPS;
3 Through stimulus of LPS,there were not obvious difference about levels of CRP and IL-6 from PBMC between healthy volunteers and MHD patients after 12 hours culture;so were levels of PKC and NF-κB;
4 By stimulus of LPS,compared with 1.5mmol/L calcium chloride,1.0mmol/L calcium chloride significantly increased CRP and IL-6 production of PBMC,raised levels of PKC and NF-κB within PBMC in MHD patients after 12 hours culture.
引文
[1]. Kopple JD,McCollum award lecture:Protein-energy malnutrition in maintenance dialysis patient [J]. Am J Clin nutr,1997,65:1544-1577.
[2]. Sakkas GK,Ball D,Mercer TH,et al.Atrophy of non-locomotor muscle in patients with end-stage renal failure [J].nephro Dial Transplant.2003,18:2074-2081.
[3]. Canaud B,Cristol JP,morena M,et al.Imbalance of oxidants and antioxidants in hemodialysis patients.Blood purification ,1999,17(2-3):99-106.
[4]. Stenvinkel P,Heimburger O,Paultre F,et al.Strong association between malnutrition,inflammation,and atherosclerosis in chronic renal failure.Kidney Int,1999,55:1899-1911.
[5]. Giovanni Tripepi,Francesca Mallamaci,Carmine Zoccali.Inflammation Markers,Adhesion Molecules,and All-Cause and Cardiovascular Mortality in Patients with ESRD:Searching for the Best Risk Marker by Multivariate Modeling.Journal of the American Society of Nephrology,2005,16:s83-s88.
[6]. Fellah H,Feki M,Hsairi M,et al.Hyperhomocysteinemia and End-stage Renal disease:Determinants and Association with cardiovascular disease in Tunisian Patients. Clinical chemistry&Laboratory Medicine,2003,41(5):675-680.
[7]. A Borazan,H Ustun,A Cefle,et al.Comparative efficacy of oral and intravenous s calcitriol treatment in haemodialysis patients:Effects on serum biochemistry and cytokine levels.The journal of international medical research,2003;31:489-496.
[8]. D.G.Haider,N.Leuchten,G.Schaller,et al.C-reative protein is expressed and secreted by peripheral blood mononuclear cells.Clinical and Experimental Immunology.2006;146:533-539
[9]. Xueyuan Zhou,Wenxiu Yang,Junying Li.Ca2+-and protein Kinase C-dependent signaling pathway for Nuclear Factor-kB Activation,Inducible Nitric-oxide Synthase Expression,and Tumor Necrosis factor-аProduction in Lipopolysaccharide-Stimulated Rat Peritoneal macrophages.[J] The Journal ofbiological chemistry,2006,281(42):31337-31343.
[10]. Grey A,Mitnick MA,Shapses S,et al.Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption-a clinical research center study.J Clin Endocrinal Metab 1996;81:3450-3454
[11]. Grey A,Mitnick MA,Masiukiewicz U,et al.A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo.Endocrinology 1999;140:4683-4690
[12]. Raggi P,Boulay A,Chasan-Taber S,et al.Cardiac calcification in adult hemodialysis patients.A link between end-stage renal disease and cardiovascular disease?[J] Am Coll cardiol,2002,39(4):695-701
[13]. Block GA,Klassen PS,Lazarus JM,et al.Mineral metabolism,mortality,and morbidity in maintenance hemodialysis.[J] Am soc nephrol,2004,15(8):2208-2218
[14]. Yang II,Curinga G,Giachelli CM.Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro.Kidney Int,2004,66(6):2293-2299
[15]. Huber SA,Sakkinen P,Conze D,et al.Interleukin-6 exacerbates early atherosclerosis in mice.Arterioscler Thromb Vasc Biol,1999,19:2364-2367.
[16]. Luik AJ,Spek JJ,Charra B,et a1.Arterial compliance in patients on long—treatment time dialysis [J].Nephrology Dialysis Transplant. 1997,21:2629—2632.
[17]. Schroecksnadel K, Frick B, Wirleitner B,et al. Moderate hypercysteinemia and immune activation.Curr Pharm Biotechnol, 2004,5:107-118.
[1] Rysz J,Stolarek R,Banach M, et al. TNF- a priming effect on polymorphonuclear leukocytes reactive oxygen species generation and adhesion molecule expression in hemodialyzed patients.Arch Immunol Ther Exp.2006;54(3):209-215.
[2] Xueyua Zhou,Wenxiu Yang,Junying Li.Ca2+-and protein kinase C-dependent signaling pathway for Nuclear factor-κB activation,Inducible nitric-oxide synthase expression,and tumor necrosis factor-a production in Lipopolysaccharide-stimulated rat peritoneal macrophages.The Journal of biological chemistry,2006;281,42:31337-31347.
[3] D.G.Haider,N.Leuchten,G.Schaller,etal.C-reactive protein is expressed and secreted by peripheral blood mononuclear cells.Clinical and Experimental Immunology,2006,146:533-539
[4]于宝军,夏照帆,黎介寿。钙拮抗药及烧伤血浆对大鼠PBMC内NF-κB活化和炎症介质产生的影响。医学研究生学报,2003,16(6):415-419。
[5] SILVIA CAROZZI,PIETRO MARCO CAVIGLIA [6] Horl WH.Hemodialysis membranes:interleukins,biocompatibility,and middle molecules.Journal of the American Society of Nephrology,2002,(suppl 1):62-71.
[1] Rysz J,Stolarek R,Banach M, et al. TNF-a priming effect on polymorphonuclear leukocytes reactive oxygen species generation and adhesion molecule expression in hemodialyzed patients.Arch Immunol Ther Exp.2006;54(3):209-215.
[2] BANKS J,POLLE S , NAIR SP,et a1 . Streptococcus sanguis secretes CD14-bindin proteins that stimulate cytokine synthesis:a clue to the pathogenesis of infective (bacteria1) endocarditis? [J].Microb Pathog,2002,32(3):105-1 16.
[3] Xueyua Zhou,Wenxiu Yang,Junying Li.Ca2+-and protein kinase C-dependent signaling pathway for Nuclear factor-κB activation,Inducible nitric-oxide synthase expression,and tumor necrosis factor-a production inLipopolysaccharide-stimulated rat peritoneal macrophages.The Journal of biological chemistry,2006;281,42:31337-31347.
[4] D.G.Haider,N.Leuchten,G.Schaller,etal.C-reactive protein is expressed and secreted by peripheral blood mononuclear cells.Clinical and Experimental Immunology,2006,146:533-539.
[5] XI AQ,CH U YD,LI GF,et al.Relationship between hemoglobin(Hb) concentration and TNF-a,slCAM-1,ventricular remodeling, and cardiac function in patients with congestive heart failure[J]. China Journal of Modem Medicine,2007,17(23):2875-2878.Chinese.
[6] Pertosa G,Grandaliana G,Gesualdo L.et al.Clinical relevance of cytokine production in hemodialysis.Kidney International,2000,58(76):S104-S111.
[7] Horl WH.Hemodialysis membranes:interleukins,biocompatibility,and middle molecules.Journal of the American Society of Nephrology,2002,(suppl 1):62-71.
[1] L.JIN,R.B.CALDWELL,T.LI-MASTERS,R.W.Homocysteine induces endothelial dysfunction via inhibition of Arginine transport,2007,58(2):191-206.
[2] Yamamoto M,Hara H,Adachi T.Effects of homocysteine on the binding of extracellular superoxide dismutase to the endothelial cell surface. FEBS Lett,2000,486:159-162.
[3] Riksen NP,Rongen GA, Blom HJ,et al. Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia.Cardiovas Res,2003,59:271-276.
[4] Lee SJ, Kim KM,Namkoong S,et al. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine.J Biol Chem,2005,280:5781-5788.
[5] Guilland JC,Favier A,Potier de Courcy G,et al.[Hyperhomocysteinemia:an independent risk factor or a simple marker of vascular disease?1.Basic data].Pathol Biol ,2003,51:101-110.
[6] Ferguson E,Hogg N,Antholine WE,et al. Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: antioxidant implications.Free Radic.Biol Med,1999,26:968-977.
[7] Hulthe J. Antibodies to oxidized LDL in atherosclerosis development clinical and animal studies. Clin Clim Acta,2004,348:1-8.
[8] Jakubowski H.: Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans.Clin Chem Lab Med,2003,41:1462-1466.
[9] Boger R.H.: The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.Cardiovasc.Res,2003,59:824-833.
[10] Wang G,Dai J,Mao J,et al. Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis,2005,179:395-402.
[11] Schroecksnadel K, Frick B, Wirleitner B,et al. Moderate hypercysteinemia and immune activation.Curr Pharm Biotechnol, 2004,5:107-118.
[12] Sherifa A,Hamed ,Toshitaka Nabeshima. The high atherosclerotic risk among Epileptics: the atheroprotective role of multivitamins. J Pharmacol Sci,2005,98:340-353.
[1] Semenza GL,Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhance at a site required for transcriptional activation. Mol Cell Biol, 1992,12(12):5447-5454.
[2] Lee JW, Bae SH, Jeo J W,et al.Hypoxia-inducible factor(HIF-1) alpha: Its protein stability and biological functions. Exp Mol Med,2004,36(1):1-12.
[3] Tian H, McKnight SL,Russell DW. Endothelial PAS domain protein 1, a transcription factor selectively expressed in endothelial cells. GenesDev,1997,11:72-82.
[4] Bernhardt WM, Schmitt R, Rosenberger C,et al. Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int, 2006,69:114-122.
[5] Schofield CJ,Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol .2004,5:343-354.
[6] Maxwell P, Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther 2004,3:29-35.
[7] Zeisberg M,Strutz F, Muller GA. Role of fibroblast activation in inducing interstitial fibrosis.J Nephrol,2000,13 Suppl 3;S111-120.
[8] Fine LG, Norman JT. The breathing kidney, J Am Soc Nephrol, 2002,13: 1974-1976.
[9] Kalluri R,Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003,112:1776-1784.
[10] Higgins DF, Johnson RS, Haase VH. Hypoxia signaling enhances renal fibrosis .Silverthorne,CO:Keystone Symposia on Molecular and Cellular Biology,2006,p.74.
[11] Cowden Dahl KD, Fryer BH, Mack FA.Hypoxia-inducible factors 1a and 2 a regulate trophoblast differentiation. Mol Cell Biol, 2005,25:10479-10491.
[12] Sharma K,Ziyadeh FN. The emerging role of transforming growth factor-beta in kidney disease.Am J Physiol,1994,266: F829-F842.
[13] Jill T, Norman, Ian M, et al. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int, 2000,58:2351-2366.
[14] Cheng O, Thuilier R, Sampson E,et al. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J transplant,2006,6:2292-2306.
[15] Orphanides C, Fine LG, Norman JT.Hypoxia promotes proximal tubular cell matrix production via a TGF- ?1-independent mechanism. Kidney Int , 1997, 52:637-647.
[16] Sanchez-Elsner T, Botella LM, Velasco B, et al. Synergistic cooperation between hypoxia and transforming growth factor- ? pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001, 276: 38527-38535.
[17] Norman JT, Clark IM,Garcia PL, et al. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int ,2000,58: 2351-2366.
[18] Kietzmann T,Roth U,Jungermann K, et al. Induction of the plasminogen activator inhibitor factor-1 in rat hepatocytes. Blood,1999,94: 4177-4185.
[19] Higgins DF, Biju MP, Akai Y,et al. Hypoxic induction of ctgf is directly mediated by HIF-1. Am J Physiol Renal Physiol,2004,287:1223-1234.
[20] Sanchez-Elsner T, Botella LM, Velasco B, et al. A cross-talk between hypoxia and TGF-? orchestrates erythropoietin gene regulation through SP1 and Smads.J Mol Biol ,2004, 336;9-24.
[21] Zhang H, Akman HO,Smith EL,et al.Cellular response to hypoxia involves signaling via Smad proteins. Blood, 2003,101:2253-2260.
[22] Kopp JB, Factor VM,Mozes M,et al.Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest,1996,74(6):991-1003.
[23] Kong T, Eltzschig Hk, Karhausen J, et al. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of ?2 integrin gene expression. Proc Nalt Acad Sci USA, 2004,101: 10440-10445.
[24] Neumann AK, Yang J, Biju Mp, et al. hypoxia inducible factor 1a regulates T cell receptor signal transduction. Proc Acad Sci USA, 2005,102: 17071-17076.
[2]. Sakkas GK,Ball D,Mercer TH,et al.Atrophy of non-locomotor muscle in patients with end-stage renal failure [J].nephro Dial Transplant.2003,18:2074-2081.
[3]. Canaud B,Cristol JP,morena M,et al.Imbalance of oxidants and antioxidants in hemodialysis patients.Blood purification ,1999,17(2-3):99-106.
[4]. Stenvinkel P,Heimburger O,Paultre F,et al.Strong association between malnutrition,inflammation,and atherosclerosis in chronic renal failure.Kidney Int,1999,55:1899-1911.
[5]. Giovanni Tripepi,Francesca Mallamaci,Carmine Zoccali.Inflammation Markers,Adhesion Molecules,and All-Cause and Cardiovascular Mortality in Patients with ESRD:Searching for the Best Risk Marker by Multivariate Modeling.Journal of the American Society of Nephrology,2005,16:s83-s88.
[6]. Fellah H,Feki M,Hsairi M,et al.Hyperhomocysteinemia and End-stage Renal disease:Determinants and Association with cardiovascular disease in Tunisian Patients. Clinical chemistry&Laboratory Medicine,2003,41(5):675-680.
[7]. A Borazan,H Ustun,A Cefle,et al.Comparative efficacy of oral and intravenous s calcitriol treatment in haemodialysis patients:Effects on serum biochemistry and cytokine levels.The journal of international medical research,2003;31:489-496.
[8]. D.G.Haider,N.Leuchten,G.Schaller,et al.C-reative protein is expressed and secreted by peripheral blood mononuclear cells.Clinical and Experimental Immunology.2006;146:533-539
[9]. Xueyuan Zhou,Wenxiu Yang,Junying Li.Ca2+-and protein Kinase C-dependent signaling pathway for Nuclear Factor-kB Activation,Inducible Nitric-oxide Synthase Expression,and Tumor Necrosis factor-аProduction in Lipopolysaccharide-Stimulated Rat Peritoneal macrophages.[J] The Journal ofbiological chemistry,2006,281(42):31337-31343.
[10]. Grey A,Mitnick MA,Shapses S,et al.Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption-a clinical research center study.J Clin Endocrinal Metab 1996;81:3450-3454
[11]. Grey A,Mitnick MA,Masiukiewicz U,et al.A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo.Endocrinology 1999;140:4683-4690
[12]. Raggi P,Boulay A,Chasan-Taber S,et al.Cardiac calcification in adult hemodialysis patients.A link between end-stage renal disease and cardiovascular disease?[J] Am Coll cardiol,2002,39(4):695-701
[13]. Block GA,Klassen PS,Lazarus JM,et al.Mineral metabolism,mortality,and morbidity in maintenance hemodialysis.[J] Am soc nephrol,2004,15(8):2208-2218
[14]. Yang II,Curinga G,Giachelli CM.Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro.Kidney Int,2004,66(6):2293-2299
[15]. Huber SA,Sakkinen P,Conze D,et al.Interleukin-6 exacerbates early atherosclerosis in mice.Arterioscler Thromb Vasc Biol,1999,19:2364-2367.
[16]. Luik AJ,Spek JJ,Charra B,et a1.Arterial compliance in patients on long—treatment time dialysis [J].Nephrology Dialysis Transplant. 1997,21:2629—2632.
[17]. Schroecksnadel K, Frick B, Wirleitner B,et al. Moderate hypercysteinemia and immune activation.Curr Pharm Biotechnol, 2004,5:107-118.
[1] Rysz J,Stolarek R,Banach M, et al. TNF- a priming effect on polymorphonuclear leukocytes reactive oxygen species generation and adhesion molecule expression in hemodialyzed patients.Arch Immunol Ther Exp.2006;54(3):209-215.
[2] Xueyua Zhou,Wenxiu Yang,Junying Li.Ca2+-and protein kinase C-dependent signaling pathway for Nuclear factor-κB activation,Inducible nitric-oxide synthase expression,and tumor necrosis factor-a production in Lipopolysaccharide-stimulated rat peritoneal macrophages.The Journal of biological chemistry,2006;281,42:31337-31347.
[3] D.G.Haider,N.Leuchten,G.Schaller,etal.C-reactive protein is expressed and secreted by peripheral blood mononuclear cells.Clinical and Experimental Immunology,2006,146:533-539
[4]于宝军,夏照帆,黎介寿。钙拮抗药及烧伤血浆对大鼠PBMC内NF-κB活化和炎症介质产生的影响。医学研究生学报,2003,16(6):415-419。
[5] SILVIA CAROZZI,PIETRO MARCO CAVIGLIA
[1] Rysz J,Stolarek R,Banach M, et al. TNF-a priming effect on polymorphonuclear leukocytes reactive oxygen species generation and adhesion molecule expression in hemodialyzed patients.Arch Immunol Ther Exp.2006;54(3):209-215.
[2] BANKS J,POLLE S , NAIR SP,et a1 . Streptococcus sanguis secretes CD14-bindin proteins that stimulate cytokine synthesis:a clue to the pathogenesis of infective (bacteria1) endocarditis? [J].Microb Pathog,2002,32(3):105-1 16.
[3] Xueyua Zhou,Wenxiu Yang,Junying Li.Ca2+-and protein kinase C-dependent signaling pathway for Nuclear factor-κB activation,Inducible nitric-oxide synthase expression,and tumor necrosis factor-a production inLipopolysaccharide-stimulated rat peritoneal macrophages.The Journal of biological chemistry,2006;281,42:31337-31347.
[4] D.G.Haider,N.Leuchten,G.Schaller,etal.C-reactive protein is expressed and secreted by peripheral blood mononuclear cells.Clinical and Experimental Immunology,2006,146:533-539.
[5] XI AQ,CH U YD,LI GF,et al.Relationship between hemoglobin(Hb) concentration and TNF-a,slCAM-1,ventricular remodeling, and cardiac function in patients with congestive heart failure[J]. China Journal of Modem Medicine,2007,17(23):2875-2878.Chinese.
[6] Pertosa G,Grandaliana G,Gesualdo L.et al.Clinical relevance of cytokine production in hemodialysis.Kidney International,2000,58(76):S104-S111.
[7] Horl WH.Hemodialysis membranes:interleukins,biocompatibility,and middle molecules.Journal of the American Society of Nephrology,2002,(suppl 1):62-71.
[1] L.JIN,R.B.CALDWELL,T.LI-MASTERS,R.W.Homocysteine induces endothelial dysfunction via inhibition of Arginine transport,2007,58(2):191-206.
[2] Yamamoto M,Hara H,Adachi T.Effects of homocysteine on the binding of extracellular superoxide dismutase to the endothelial cell surface. FEBS Lett,2000,486:159-162.
[3] Riksen NP,Rongen GA, Blom HJ,et al. Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia.Cardiovas Res,2003,59:271-276.
[4] Lee SJ, Kim KM,Namkoong S,et al. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine.J Biol Chem,2005,280:5781-5788.
[5] Guilland JC,Favier A,Potier de Courcy G,et al.[Hyperhomocysteinemia:an independent risk factor or a simple marker of vascular disease?1.Basic data].Pathol Biol ,2003,51:101-110.
[6] Ferguson E,Hogg N,Antholine WE,et al. Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: antioxidant implications.Free Radic.Biol Med,1999,26:968-977.
[7] Hulthe J. Antibodies to oxidized LDL in atherosclerosis development clinical and animal studies. Clin Clim Acta,2004,348:1-8.
[8] Jakubowski H.: Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans.Clin Chem Lab Med,2003,41:1462-1466.
[9] Boger R.H.: The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.Cardiovasc.Res,2003,59:824-833.
[10] Wang G,Dai J,Mao J,et al. Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis,2005,179:395-402.
[11] Schroecksnadel K, Frick B, Wirleitner B,et al. Moderate hypercysteinemia and immune activation.Curr Pharm Biotechnol, 2004,5:107-118.
[12] Sherifa A,Hamed ,Toshitaka Nabeshima. The high atherosclerotic risk among Epileptics: the atheroprotective role of multivitamins. J Pharmacol Sci,2005,98:340-353.
[1] Semenza GL,Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhance at a site required for transcriptional activation. Mol Cell Biol, 1992,12(12):5447-5454.
[2] Lee JW, Bae SH, Jeo J W,et al.Hypoxia-inducible factor(HIF-1) alpha: Its protein stability and biological functions. Exp Mol Med,2004,36(1):1-12.
[3] Tian H, McKnight SL,Russell DW. Endothelial PAS domain protein 1, a transcription factor selectively expressed in endothelial cells. GenesDev,1997,11:72-82.
[4] Bernhardt WM, Schmitt R, Rosenberger C,et al. Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int, 2006,69:114-122.
[5] Schofield CJ,Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol .2004,5:343-354.
[6] Maxwell P, Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther 2004,3:29-35.
[7] Zeisberg M,Strutz F, Muller GA. Role of fibroblast activation in inducing interstitial fibrosis.J Nephrol,2000,13 Suppl 3;S111-120.
[8] Fine LG, Norman JT. The breathing kidney, J Am Soc Nephrol, 2002,13: 1974-1976.
[9] Kalluri R,Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003,112:1776-1784.
[10] Higgins DF, Johnson RS, Haase VH. Hypoxia signaling enhances renal fibrosis .Silverthorne,CO:Keystone Symposia on Molecular and Cellular Biology,2006,p.74.
[11] Cowden Dahl KD, Fryer BH, Mack FA.Hypoxia-inducible factors 1a and 2 a regulate trophoblast differentiation. Mol Cell Biol, 2005,25:10479-10491.
[12] Sharma K,Ziyadeh FN. The emerging role of transforming growth factor-beta in kidney disease.Am J Physiol,1994,266: F829-F842.
[13] Jill T, Norman, Ian M, et al. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int, 2000,58:2351-2366.
[14] Cheng O, Thuilier R, Sampson E,et al. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J transplant,2006,6:2292-2306.
[15] Orphanides C, Fine LG, Norman JT.Hypoxia promotes proximal tubular cell matrix production via a TGF- ?1-independent mechanism. Kidney Int , 1997, 52:637-647.
[16] Sanchez-Elsner T, Botella LM, Velasco B, et al. Synergistic cooperation between hypoxia and transforming growth factor- ? pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001, 276: 38527-38535.
[17] Norman JT, Clark IM,Garcia PL, et al. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int ,2000,58: 2351-2366.
[18] Kietzmann T,Roth U,Jungermann K, et al. Induction of the plasminogen activator inhibitor factor-1 in rat hepatocytes. Blood,1999,94: 4177-4185.
[19] Higgins DF, Biju MP, Akai Y,et al. Hypoxic induction of ctgf is directly mediated by HIF-1. Am J Physiol Renal Physiol,2004,287:1223-1234.
[20] Sanchez-Elsner T, Botella LM, Velasco B, et al. A cross-talk between hypoxia and TGF-? orchestrates erythropoietin gene regulation through SP1 and Smads.J Mol Biol ,2004, 336;9-24.
[21] Zhang H, Akman HO,Smith EL,et al.Cellular response to hypoxia involves signaling via Smad proteins. Blood, 2003,101:2253-2260.
[22] Kopp JB, Factor VM,Mozes M,et al.Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest,1996,74(6):991-1003.
[23] Kong T, Eltzschig Hk, Karhausen J, et al. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of ?2 integrin gene expression. Proc Nalt Acad Sci USA, 2004,101: 10440-10445.
[24] Neumann AK, Yang J, Biju Mp, et al. hypoxia inducible factor 1a regulates T cell receptor signal transduction. Proc Acad Sci USA, 2005,102: 17071-17076.